Hair Loss Medications Market Report Disclosing Latest Clinical Advancement Outlook - 2026 | Merck, Johnson & Johnson, Gerolymatos International, Nanogen

Report Hair Loss Medications market provides a complete Overview of the pipeline activities covering all clinical, pre-clinical and discovery stage products. The report provides comprehensive insights of the ongoing therapeutic research and development. It provides pipeline product profiles which include product description, developmental activities, licensors collaborators and chemical information.

Hair-loss also was known as alopecia or baldness is a medical condition that refers to the loss of hair from the head or any part of the body.

Click the link to get a Sample Copy of the Report:

https://www.marketinsightsreports.com/reports/03241930900/global-hair-loss-medications-market-research-report-2020/inquiry?Mode=52

Global Hair Loss Medication Market is expected to grow at a CAGR of 5.25% during the forecast period (2020-2027)

Key players: Merck, Johnson & Johnson, Gerolymatos International, Nanogen, Oxford BioLabs, Ultrax Labs, Bayer, Pharma Medico, Kirkland Signature, Phyto Ales Group, Amplixin, Keranique, DS Healthcare Group

GLOBAL HAIR LOSS MEDICATIONS MARKET SPLIT BY PRODUCT TYPE AND APPLICATIONS:

The report segments the Global Hair Loss Medications Market on the basis of Types as follows:
Rx
OTC

On the basis of Application/End-Users, the Global Hair Loss Medications market is segmented into:
Male
Female
Both

News and Updates

1)In May 2018, Histogen, Inc., received approval of its investigational new drug application from the U.S. Food and Drug Administration (FDA) to study its first product Hair Stimulating Complex (HSC660) in female diffuse hair loss. HSC660 is an investigational injectable treatment for alopecia and is expected to get FDA approval shortly.

2)In April 2018, Concert Pharmaceuticals, Inc., finished patient recruitment for Phase 2a trial evaluating CTP-543 for the treatment of moderate-to-severe alopecia areata.

3)In January 2018, Concert Pharmaceuticals, Inc., a U.S.-based company received Fast Track designation from the U.S. Food and Drug Administration (FDA) for its unique product CTP-543. CTP-543 is a novel, oral Janus kinase (JAK) inhibitor for the treatment of moderate-to-severe alopecia areata.

4)In January 2018, HCell Inc., a Texas-based biotechnology company received Orphan Drug Designation (ODD) for HC017AA drug from the U.S. Food and Drug Administration (FDA). HC017AA is an underdevelopment drug indicated for non- surgical treatment for Alopecia Areata in Pediatric Patients

REGIONAL ANALYSIS FOR MARKET:
For comprehensive understanding of market dynamics, the global Hair Loss Medications market is analyzed across key geographies namely: United States, China, Europe, Japan, South-east Asia, India and others. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

According to National Alopecia Areata Foundation (NAAF), the prevalence of hair loss has increased in the age group of 10 to 25 years in the last decade, and around 60% of this age group suffers from hair loss. As per the American Hair Loss Association, more than 66% of men below the age of 35 experienced hair loss problems in the year 2018. Besides, about 85% of the men below the age of 55 are expected to face thinning of hair. More than 21 million women are suffering from severe hair loss problems with about 40% of them getting active treatments.

Browse the report description and TOC:

https://www.marketinsightsreports.com/reports/03241930900/global-hair-loss-medications-market-research-report-2020?Mode=52

KEY FINDINGS OF THE GLOBAL HAIR LOSS MEDICATIONS MARKET:

What will the market size and the growth rate be in 2026?
What are the key factors driving the Global Hair Loss Medications Market?
What are the key market trends impacting the growth of the market?
What are the challenges to market growth?
Who are the key vendors in the Global Hair Loss Medications Market?
What are the market opportunities and threats faced by the vendors in this market

Related reports:

https://www.marketinsightsreports.com/reports/01091744523/hair-loss-treatment-products-market-growth-trends-and-forecast-2020-2025?Mode=52

About Us
MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations

CONTACT US:
Irfan Tamboli (Head of Sales) - Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com

irfan@marketinsightsreports.com

This release was published on openPR.